Optic Neuritis Treatment Market Share

North American Market Forecast

Optic neuritis treatment market in North America is predicted to account for the largest share of 35% by the end of 2036 impelled by the higher adoption of steroids. As a result, it may increase access to steroid treatment for optic neuritis in the region. More than 3% of high school seniors in the US have used steroids at least once in their lifetime, and almost half a million youngsters use them annually

APAC Market Statistics

The Asia Pacific optic neuritis treatment market is estimated to be the second largest, during the forecast timeframe led by the growing prevalence of herpes, mumps, and measles. Growing cases of these viral infections may potentially result in optic neuritis in a higher number of individuals in the region. Since it is a secondary condition resulting from the immune response to the viral infection which can cause inflammation in the optic nerve. For instance, in countries like Sri Lanka, China, and others, more than 95% of children up to 23 months old were observed to be immunized against measles.